e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The efficacy of Phoenix dactylifera L. sap for the treatment of lung injury in a murine model of pulmonary fibrosis
S. BAHRI (Tunis, Tunisia), R. Abdennabi (Sfax, Tunisia), R. Ben Ali (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), N. Gharsallah (Athens, Greece), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
Source:
International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Session:
Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Session type:
Poster Discussion
Number:
3718
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. BAHRI (Tunis, Tunisia), R. Abdennabi (Sfax, Tunisia), R. Ben Ali (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), N. Gharsallah (Athens, Greece), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). The efficacy of Phoenix dactylifera L. sap for the treatment of lung injury in a murine model of pulmonary fibrosis. 3718
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Nigella sativa fixed oil, attenuates bleomycin-induced pulmonary fibrosis in a rat model
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Coix lacryma-jobi L. var. ma-yuen Stapf sprout extract (CLSE) protects against cigarette smoke-induced lung inflammation in rats
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Anti-fibrotic and antioxidant effects of Ailanthus altissima wood aqueous extract against bleomycin-induced lung fibrosis in rat
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
Glycine efficacy for prevention or treatment on LPS-acute lung injury in mice
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Effect of Pistacia lentiscus oil on inflammatory infiltrate in experimental lung fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Effect of thymus vulgaris leaf extract on bleomycin induced oxidative stress and lung fibrosis in rats
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Sustained PAP-reduction and tissue cGMP-restoration without systemic NO-generation by aerosolized PAPA-NONOate in an isolated lung model of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept